Lifecore Biomedical, Inc. (LFCR)

NASDAQ: LFCR · Real-Time Price · USD

6.40

-0.12 (-1.84%)

At close: Oct 30, 2026, 4:00 PM EDT

6.39

-0.01 (-0.16%)

After-hours: Oct 30, 2026, 7:30 PM EDT

Lifecore Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022
Market Capitalization	242	306	249	172	241	291
Market Cap Growth	-8.27%	23.18%	44.93%	-28.69%	-17.27%	-17.12%
Enterprise Value	369	472	419	305	395	424
Last Close Price	6.40	8.18	6.72	5.62	7.94	9.87

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022
PE Ratio	-	-	-	14.29	-	-
Forward PE	-	8.17	8.17	25.55	167.00	250.59
PS Ratio	1.87	2.37	1.93	1.34	2.33	2.62
PB Ratio	7.11	9.00	5.25	3.19	6.86	3.31
P/TBV Ratio	-	-	-	-	-	4.17
P/FCF Ratio	38.89	49.20	-	-	-	-
P/OCF Ratio	19.28	24.39	-	667.99	-	-
PEG Ratio	-	25.06	25.06	25.06	25.06	25.06

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022
EV/Sales Ratio	2.85	3.65	3.25	2.37	3.82	3.81
EV/EBITDA Ratio	44.71	57.32	-	123.49	-	29.82
EV/FCF Ratio	59.15	75.84	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022
Debt / Equity Ratio	4.22	4.22	2.76	2.39	3.21	1.71
Debt / EBITDA Ratio	16.83	16.83	-	43.34	-	9.63
Debt / FCF Ratio	23.07	23.07	-	-	-	-
Net Debt / Equity Ratio	3.71	3.71	2.58	2.23	2.67	1.70
Net Debt / EBITDA Ratio	15.32	15.32	-30.80	48.73	-13.28	10.49
Net Debt / FCF Ratio	20.27	20.27	-9.00	-6.62	-2.40	-2.84
Asset Turnover	-	-	0.52	0.51	0.39	0.29
Inventory Turnover	-	-	2.45	2.14	1.96	1.46
Quick Ratio	2.18	2.18	1.46	1.02	1.23	0.22
Current Ratio	3.49	3.49	2.84	2.09	2.39	0.66
Return on Equity (ROE)	-	-	-76.41%	20.97%	-104.52%	-10.65%
Return on Assets (ROA)	-	-	-3.04%	-1.35%	-4.67%	-0.55%
Return on Invested Capital (ROIC)	-0.76%	-0.76%	-6.98%	-3.56%	-10.79%	-1.05%
Return on Capital Employed (ROCE)	-0.60%	-0.60%	-5.70%	-2.60%	-9.20%	-3.50%

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 30, 2026	Dec '25 Dec 31, 2025	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022
Earnings Yield	-14.46%	-10.05%	-15.56%	7.00%	-41.36%	-40.11%
FCF Yield	2.57%	2.03%	-5.47%	-10.56%	-16.17%	-18.05%
Buyback Yield / Dilution	-1.63%	-7.33%	5.02%	-22.36%	-1.67%	-0.59%

SEC Filings: 10-K · 10-Q